Expression of tenascin-C in aseptic loosening of total hip replacement

Annals of the Rheumatic Diseases

Volumn 57, Issue 10, 1998, Pages 619-623

  Konttinen, Yrjö T ^a,b   Li, Tian Fang ^a,b   Michelsson, Oliver ^b   Xu, Jing Wen ^c   Sorsa, Timo ^b   Santavirta, Seppo ^a   Imai, Shinji ^b   Virtanen, Ismo ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MEMBRANE METALLOENDOPEPTIDASE; TENASCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FOREIGN BODY REACTION; HUMAN; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE INJURY; TOTAL HIP PROSTHESIS;

EID: 0031790482     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.10.619     Document Type: Article

References (44)

1. Dvorak HF. Tumor wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1996;315:1650-9.
2. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development 1993; 117:1183-98
3. Li TF, Konttinen YT, Xu JW, Imai S, Matucci-Cerinic M, Ceponis A, et al. Tenascin expression in some normal and pathologic conditions of the museuloskeletal system. Biomed Rev 1996;6:83-94.
4. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
5. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol 1991;22:636-43.
6. Latijnhouwers MA, Bergers M, Van Bergen BH, Spruijt KI, Andriessen MP, Schalkwijk J. Tenascin expression during wound healing in human skin. J Pathol 1996;178:30-5.
7. Gould VE, Martinez-Lacabe V, Virtanen I, Sahlin KM, Schwartz MM. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. Lab Invest 1992;67:71-9.
8. Chevalier X, Groult N, Larget-Piet B, Zardi L, Hornebeck W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1994;37:1013-22.
9. Päällysaho T, Tervo K, Kivelä T, Virtanen I, Tarkkanen A, Tervo T. Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of an infection caused by Staphylococcus aureus. Graefes Arch Clin Exp Ophthalmol 1993;231:61-5.
10. Luomanen M, Virtanen I. Distribution of tenascin in healing incision, excision and laser wounds. J Oral Pathol Med 1993;22:41-5.
11. Harris WH. Excellence pays. In: Harris WH, ed. Total hip replacement. 26th Annual Course. Boston: Harvard Medical School, 1996.
12. Jiranek WA. Arthritis of the hip: magnitude of the problem and its cost. In: Harris WH, ed. Total hip replacement. 26th Annual Course. Boston: Harvard Medical School, 1996.
13. Wooley PH, Nasser S, Fitzgerald RH Jr. The immune response to implant materials in humans. Clin Orthop 1996;326:63-70.
14. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg 1990;72A:252-8.
15. Tiitta O, Wahlström T, Paavonen J, Linnala A, Sharma S, Gould VE, et al. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol 1992;141:907-13.
16. Aukhil I, Hoshi P, Yan Y, Erickson HP. Cell- and heparin-binding domains of the hexabracion arm identified by tenascin expression proteins. J Biol Chem 1993;268: 2542-53.
17. Ekblom P, Aufderheide E. Stimulation of tenascin-C expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol 1989;33:71-9.
18. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 1987;105:2569-79.
19. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 1988;31: 956-63.
20. Salter DM. Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol 1993;32:780-6.
21. Carter DH, Sloan P, Aaron JE. Immunolocalization of collagen types I and III, tenascin, and fibronectin in intramembranous bone. J Histochem Cytochem 1991;39: 599-606.
22. Hasegawa T, Seki K, Yang P, Hirose T, Hizawa K, Wada T, et al. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol 1995;26: 838-45.
23. Cutolo M, Picasso M, Ponassi M, Sun MZ, Balza E. Tenascin and fibronectin distribution in human normal and pathological synovium. J Rheumatol 1992;19:1439-47.
24. Santavirta S, Konttinen YT, Hoikka V, Eskola A. Immunopathological response to loose cementless acetabular components. J Bone Joint Surg 1991;73B:38-42.
25. Muller-Ladner U, Kriegsmann J, Geiler T, Gay RE, Gay S. Synovial mesenchymal reaction as a perpetuating principle. Scand J Rheumatol Suppl 1995;101:115-19.
26. Fassbender HG, Gay S. Synovial processes in rheumatoid arthritis. Scand J Rheumatol Suppl 1988;76:1-7.
27. Rettig WJ, Erickson HP, Albino AP, Garin-Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J Cell Sci 1994;107:487-97.
28. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensm II. Am J Pathol 1992;141:377 88.
29. Tucker RP, Hammarback JA, Jenrath DA, Mackie EJ, Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 1993:104:69-76.
30. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J 1988;7:2977-82.
31. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, et al. Production of cytokines around loosened cemented acetabular components. Analysis with immnunohistochemical techniques and in situ hybridization. J Bone Joint Surg 1993;75A:863-79.
32. Konttinen YT, Kurvinen H, Tagaki M, Michelsson JE, Eklund KK, Nordsletten L, et al. Interleukin-1 and collagenases around loosening total hip prosthesis. Clin Exp Rheumatol 1996;14:255-62.
33. Xu JW, Konttinen YT, Lassus J, Natah S, Ceponis A, Solovieva S, et al. Tumor necrosis factor-alpha (TNF-α) in loosening of total hip replacement (THR). Clin Exp Rheumatol 1996;14:643-8.
34. Waris V, Xu JW, Nordsletten L, Sorsa T, Santavirta S, Konttinen YT. Basic fibroblast growth factor (bFGF) in the synovial-like membrane around loose total hip prostheses. Scand J Rheumatol 1996;25:257-62.
35. Konttinen YT, Waris V, Xu JVC, Jiranek WA, Sorsa T, Virtanen I, et al. Transforming growth factor-β (TGF-β) 1 and 2 in the synovial-like interface membrane between the implant and bone in loosening of total hip replacement (THR). J Rheumatol 1997;24:694-701.
36. Konttinen YT, Xu J-W, Pätiälä H, Imai S, Waris V, Li T-F, et al. Cytokines in aseptic loosening of total hip replacement. Current Orthop 1997;11:40-7.
37. Sage EH, Bornstein P. Extracellular proteins that modulate cell matrix intraction. J Biol Chem 1991;266:14831-4.
38. Chung CY, Murphy-Ullrich JE, Erickson HP. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 1996;7:883-92.
39. Mackie EJ, Halfter W, Liverani D. Induction of tenascin-C in healing wounds. J Cell Biol 1988;107:2757-67.
40. Santavirta S, Sorsa T, Konttinen YT, Saari H, Eskola A, Eisen AZ. Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop 1993;290:206-15.
41. Santavirta S, Takagi M, Konttinen YT, Sorsa T, Suda T. Inhibitory effect of cepholothin on matrix metalloproteinase activity around loose hip prosthesis. Antimicrob Agents Chemother 1996;40244-6.
42. Takagi M, Konttinen YT, Santavirta S, Sorsa T, Eisen AZ, Nordsletten L, et al. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 1994;65:281-6.
43. Takagi M, Konttinen YT, Lindy O, Sorsa T, Kurvinen H, Suda A, et al. Gelatinase type IV collagenases in the loosening of total hip replacement endoprostheses. Clin Orthop 1994;306:136-44.
44. Takagi M, Konttinen YT, Kemppinen P, Sorsa T, Tschesche H, Blaser J, et al. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses. J Rheumatol 1995;22:2285-90.